Dayvigo

Insomnia Treatment

Dayvigo is primarily prescribed for the treatment of insomnia in adults. Insomnia is a sleep disorder where individuals have persistent trouble with their sleep patterns. This medication is specifically indicated for two main types of sleep issues:

• Sleep onset: Difficulty falling asleep at the beginning of the night.
• Sleep maintenance: Difficulty staying asleep throughout the night or waking up too early and being unable to return to sleep.

By addressing both falling asleep and staying asleep, the medication aims to improve the overall quality and duration of rest for those struggling with chronic sleep disturbances.

The Orexin System

To understand how Dayvigo works, it is helpful to understand the role of orexin. Orexin is a natural chemical in the brain that helps regulate the sleep-wake cycle. Its primary job is to keep you awake, alert, and focused during the day.

Mechanism of Action

Dayvigo belongs to a class of medications called dual orexin receptor antagonists (DORAs). It works by blocking the action of orexin at two specific receptors in the brain. By interfering with these wake-promoting signals, the medication helps the brain transition from a state of wakefulness into sleep.

Effects on Sleep

By suppressing the signals that keep you awake, Dayvigo can help with two main aspects of insomnia:

• Falling asleep: It reduces the time it takes to transition from being awake to being asleep.
• Staying asleep: It helps decrease the number of times you wake up during the night and the amount of time spent awake after initially falling asleep.

Unlike some other types of sleep aids that act as general sedatives to slow down brain activity, Dayvigo specifically targets the chemical pathways responsible for wakefulness.

Common Side Effects

The most frequently reported side effect of Dayvigo is somnolence, which is a feeling of extreme sleepiness or grogginess during the day. Other common side effects include:

• Fatigue or tiredness
• Headache
• Nightmares or unusual dreams

Serious Side Effects

While less common, some people may experience serious side effects that require medical attention. These include:

• Complex sleep behaviors: Getting out of bed while not fully awake and performing activities such as sleepwalking, driving a car, preparing food, or making phone calls. You may not remember these activities the next morning.
• Sleep paralysis: A temporary inability to move or talk for up to several minutes while falling asleep or waking up.
• Hallucinations: Seeing or hearing things that are not there, often occurring just as you are falling asleep or waking up.
• Cataplexy-like symptoms: Sudden muscle weakness in the legs that can last from seconds to a few minutes, typically occurring during the day or night.
• Mood changes: Worsening depression or new thoughts of self-harm.

Next-Day Impairment

Dayvigo can impair your alertness and motor coordination the day after taking it. This risk increases if you do not get a full night's sleep (at least 7 hours) or if you take a higher dose. You should be cautious when driving or operating machinery until you know how the medication affects you.

Daytime Impairment

Dayvigo can impair alertness and motor coordination, including the ability to drive. This risk increases with higher doses or if the medication is taken without a full night of sleep (at least 7 hours). Combining this medication with alcohol or other central nervous system depressants, such as opioids, can further increase the risk of severe drowsiness and respiratory depression.

Complex Sleep Behaviors

Some people taking Dayvigo have experienced complex sleep behaviors, such as sleep-walking, sleep-driving, preparing food, or making phone calls while not fully awake. These activities can occur even after the first dose. Because these behaviors can result in serious injury or death, the medication should be discontinued immediately if they occur.

Contraindications

Dayvigo is contraindicated in individuals with narcolepsy, a condition characterized by sudden sleep attacks and excessive daytime sleepiness.

Sleep Paralysis and Hallucinations

This medication may cause symptoms similar to those seen in narcolepsy, including:

• Sleep paralysis: An inability to move or speak for several seconds or minutes while falling asleep or waking up.
• Hallucinations: Vivid or disturbing perceptions that occur during sleep-wake transitions.
• Cataplexy-like symptoms: Sudden muscle weakness that can last from seconds to minutes.

Mental Health and Respiratory Function

In patients with depression, sleep medications may worsen symptoms or increase suicidal thoughts. Dayvigo should be used with caution in these individuals. Additionally, its effects on respiratory function in people with chronic obstructive pulmonary disease (COPD) or obstructive sleep apnea (OSA) have not been fully established, so caution is advised for those with compromised breathing.

Pregnancy

There are currently no adequate studies on the use of Dayvigo in pregnant women to determine if there is a drug-associated risk of birth defects or miscarriage. In animal studies, high doses of the medication were associated with decreased body weight and other developmental issues in offspring, though these doses were significantly higher than the maximum recommended human dose.

A pregnancy exposure registry is available to monitor the outcomes of individuals who take Dayvigo while pregnant. Healthcare providers may encourage patients to enroll in this registry to help gather more information about the drug's safety during pregnancy.

Breastfeeding

It is not known whether Dayvigo passes into human breast milk, how it affects a nursing infant, or if it impacts milk production. Research in animals has shown that the medication and its byproducts are present in the milk of lactating rats. Because the effects on a human infant are unknown, patients should talk to their doctor about the best way to feed their baby while taking this medication.

Dosage Forms

Dayvigo is available as a film-coated tablet for oral administration. It is designed to be taken by mouth once daily, shortly before bedtime.

The tablets are manufactured in different strengths. Each strength is distinguished by its specific color and the identifying characters imprinted on the tablet surface. A healthcare provider will determine the appropriate strength based on medical history and individual response to the treatment.

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Dayvigo (lemborexant) in 2019 for the treatment of insomnia in adults. It is specifically indicated for patients who experience difficulties with sleep onset, sleep maintenance, or both.

Controlled Substance Classification

Dayvigo is classified by the Drug Enforcement Administration (DEA) as a Schedule IV controlled substance. This designation indicates that the medication has a potential for abuse or dependence. Healthcare providers are advised to monitor patients with a history of drug or alcohol abuse for signs of misuse or addiction.

Safety and Regulatory Labeling

The FDA requires specific warnings on the labeling for Dayvigo to address potential safety concerns. These include:

• Daytime Impairment: There is a risk of next-day drowsiness and impaired driving or alertness, particularly if a full night of sleep (at least 7 hours) is not achieved.
• Complex Sleep Behaviors: There are risks of performing activities while not fully awake, such as sleep-walking or sleep-driving, which can lead to serious injury or death.
• Mental Health Considerations: Regulatory guidelines require warnings regarding the potential for worsening depression or suicidal thoughts in patients using sedative-hypnotic medications.
• Respiratory Function: While Dayvigo has been studied in patients with mild to moderate respiratory issues, the FDA-approved labeling notes that its effects on respiratory function should be considered in patients with compromised breathing.

How Dayvigo Treats Insomnia

Dayvigo is a sedative-hypnotic medication used to manage insomnia in adults. It works differently than many traditional sleep medications by targeting the orexin system in the brain. Orexin is a neurotransmitter responsible for maintaining wakefulness; by blocking its receptors, Dayvigo helps suppress the wake drive, allowing sleep to occur.

Sleep Onset and Maintenance

The medication is used to treat two primary symptoms of insomnia:

• Sleep onset: Helping individuals who have trouble falling asleep at the start of the night.
• Sleep maintenance: Helping individuals who wake up during the night or too early in the morning and have trouble returning to sleep.

Clinical studies have shown that Dayvigo can decrease the time it takes to fall asleep and reduce the amount of time spent awake after initially falling asleep.

Administration for Best Results

For the treatment of insomnia, Dayvigo is taken as a tablet once per night. It should be taken immediately before getting into bed, as it works quickly. Users should only take the medication when they have at least 7 hours to remain asleep before they need to be active or drive. Taking the drug with food may slow its onset, meaning it might take longer to fall asleep than if taken on an empty stomach.